-
-
-
-
-
-
-
Optimi Health to start Phase 2 psilocybin trial for depression
-
-
-
-
-
-
-
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
-
-
-
-
-
-
-
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
-
-
-
-
-
-
-
Optimi Health completes psilocybin production for Australian market
-
-
-
-
-
-
-
Optimi Health closes $15 million public offering for NASDAQ listing
-
-
-
-
-
16,229 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

